The purpose of this study was to determine how well patients could correctly recognize and comprehend the various information items in over-the-counter (OTC) medications package leaflets in Saudi Arabia.
Methods:
Leaflets from 20 most commonly sold OTC medications were examined by experts to evaluate the leaflet layout, language, and content. The same leaflets were also evaluated by patients who had their medicines dispensed at 2 hospitals and 8 community pharmacies in Al Kharj, Saudi Arabia. A questionnaire was used for the patients’ examination.
Results:
A total of 479 questionnaires were included in the study. Each package leaflet was examined by at least 20 participants. The results indicate poor comprehensibility, for many items, particularly items regarding “drug interactions” and “contraindications.”
Conclusion:
The participants had some difficulty recognizing and comprehending certain information items in the package leaflets that are supplied with OTC medications in Saudi Arabia.
AljadheyHAssiriGMahmoudMAl-AqeelSMurrayM. Self-medication in Central Saudi Arabia. Community pharmacy consumers’ perspectives. Saudi Med J. 2015;36:328–334. doi:10.15537/smj.2015.3.10523.
2.
Al-MohamadiABadrABin MahfouzLSamargandiDAl AhdalA. Dispensing medications without prescription at Saudi community pharmacy: extent and perception. Saudi Pharm J. 2013;21:13–18. doi:10.1016/j.jsps.2011.11.003.
3.
AlaqeelSAbanmyNO. Counselling practices in community pharmacies in Riyadh, Saudi Arabia: a cross-sectional study. BMC Health Serv Res. 2015;15:557. doi:10.1186/s12913-015-1220-6.
4.
RaynorDKTSvarstadBKnappP. Consumer medication information in the United States, Europe, and Australia: a comparative evaluation. Am Pharm. 2007:717–724. doi:10.1331/JAPhA.2007.06141.
US Food and Drug Administration. Guidance for industry: label comprehension studies for nonprescription drug products. Fed Regist. 2000;65:7764–7787.
7.
PiresCVigárioMCavacoA. Readability of medicinal package leaflets: a systematic review. Rev Saude Publica. 2015;49. doi:10.1590/S0034-8910.2015049005559.
8.
TongVRaynorDKAslaniP. Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review. Int J Clin Pharm. 2014;36:865–872. doi:10.1007/s11096-014-9975-0.
9.
LukAAslaniP. Tools used to evaluate written medicine and health information: document and user perspectives. Health Educ Behav. 2011;38:389–403. doi:1090198110379576 [pii]\r10.1177/1090198110379576 [doi].
FuchsJ. The way forward in package insert user tests from a CRO’s perspective. Drug Inf J. 2010;44:119–129.
12.
GustafssonJKälvemarkSNilssonGNilssonJLG. Patient information leaflets—patients’ comprehension of information about interactions and contraindications. Pharm World Sci. 2005;27:35–40. http://www.ncbi.nlm.nih.gov/pubmed/15861933.
13.
Pander MaatHLentzL. Improving the usability of patient information leaflets. Patient Educ Couns. 2010;80:113–119. doi:10.1016/j.pec.2009.09.030.
14.
DickinsonDRaynorDKDumanM. Patient information leaflets for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43:147–159. http://www.ncbi.nlm.nih.gov/pubmed/11369148. Accessed March 17, 2016.
15.
ShiffmanSGerlachKKSembowerMARohayJM. Consumer understanding of prescription drug information: an illustration using an antidepressant medication. Ann Pharmacother. 2011;45:452–458. doi:10.1345/aph.1P477.
16.
Al-AqeelSA. Evaluation of medication package inserts in Saudi Arabia. Drug Healthc Patient Saf. 2012;4:33–38. doi:10.2147/DHPS.S29402.
BungeMMühlhauserISteckelbergA. What constitutes evidence-based patient information? Overview of discussed criteria. Patient Educ Couns. 2010;78:316–328. doi:10.1016/j.pec.2009.10.029.
19.
PiresCVigárioMCavacoA. Factors influencing subjects’ comprehension of a set of medicine package inserts. Int J Clin Pharm. 42016. doi:10.1007/s11096-016-0305-6.
20.
Executive Board of the Health Ministers’ Council for GCC States. The GCC Guidance for Presenting the SPC, PIL and Labeling Information. 2011:1–52. file:///C:/Users/aldor/Downloads/Guidance for SPC PIL SFDA version 2.0 (1).pdf.
21.
GarnerMNingZFrancisJ. A framework for the evaluation of patient information leaflets. Health Expect. 2012;15:283–294. doi:10.1111/j.1369-7625.2011.00665.x.
